Immunogenicity of a Reduced Schedule of Pneumococcal Conjugate Vaccine in Healthy Infants and Correlates of Protection for Serotype 6B in the United Kingdom
about
The host immune dynamics of pneumococcal colonization: implications for novel vaccine developmentThe potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experienceUsing the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and WalesPediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in DenmarkImmunogenicity of seven-valent pneumococcal conjugate vaccine administered at 6, 14 and 40 weeks of age in South African infantsThe Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Herd Immunity in High-Income Countries.Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules.The history of pneumococcal conjugate vaccine development: dose selection.Antibody concentrations against the infecting serotype in vaccinated and unvaccinated children with invasive pneumococcal disease in the United Kingdom, 2006-2013.Radical serotype rearrangement of carried pneumococci in the first 3 years after intensive vaccination started in Hungary.Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014.
P2860
Q28084920-5DF023D3-C10A-4E2D-91FF-3E5EDF8377FAQ28088507-880AF494-5C54-41EB-A63A-3A02EA5A3F8DQ28742003-135C9600-C963-439B-8ADE-6373F6C2EBFEQ34568186-89F19656-ABD2-4F91-B9E8-8AA4FC6C0763Q34981631-14E83199-8B0B-4AA0-AC84-0E8B942A7029Q35658460-A7CFB0FF-C55A-4F01-AEC3-0D71CBCE6D47Q37951530-34276BE1-A6DB-4F09-B3ED-DF5DD14CC205Q38160248-6D01E927-749B-4EAF-821F-F2970FA1A9DEQ41451800-55CC2C60-186B-4E88-9410-2C0545E56A38Q41758733-B1DF1080-DABB-4AC2-964D-7A3D193A74E1Q47663756-BB942326-4434-4EA8-B7CE-8086A7E73493
P2860
Immunogenicity of a Reduced Schedule of Pneumococcal Conjugate Vaccine in Healthy Infants and Correlates of Protection for Serotype 6B in the United Kingdom
description
im Mai 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 May 2010
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2010
@uk
name
Immunogenicity of a Reduced Sc ...... otype 6B in the United Kingdom
@en
Immunogenicity of a Reduced Sc ...... otype 6B in the United Kingdom
@nl
type
label
Immunogenicity of a Reduced Sc ...... otype 6B in the United Kingdom
@en
Immunogenicity of a Reduced Sc ...... otype 6B in the United Kingdom
@nl
prefLabel
Immunogenicity of a Reduced Sc ...... otype 6B in the United Kingdom
@en
Immunogenicity of a Reduced Sc ...... otype 6B in the United Kingdom
@nl
P2093
P1476
Immunogenicity of a reduced sc ...... otype 6B in the United Kingdom
@en
P2093
Elizabeth Miller
Jo Southern
Lindsey Ashton
Nick Andrews
Pauline Waight
Polly Burbidge
Sarah Woodgate
P304
P356
10.1097/INF.0B013E3181C67F04
P577
2010-05-01T00:00:00Z